Zobrazeno 1 - 10
of 67
pro vyhledávání: '"C Robin, Hiley"'
Autor:
Lyudmyla Borysova, Kim A. Dora, Josh F. Smith, C. Robin Hiley, Hamish A.L. Lemmey, Christopher J. Garland
Publikováno v:
Hypertension (Dallas, Tex. : 1979)
Supplemental Digital Content is available in the text.
Endothelial dysfunction in small arteries is a ubiquitous, early feature of cardiovascular disease, including hypertension. Dysfunction reflects reduced bioavailability of endothelium-derive
Endothelial dysfunction in small arteries is a ubiquitous, early feature of cardiovascular disease, including hypertension. Dysfunction reflects reduced bioavailability of endothelium-derive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f63563e6ba8ee0f1b90dca07854baee
https://doi.org/10.1161/hypertensionaha.120.15491
https://doi.org/10.1161/hypertensionaha.120.15491
Autor:
C. Robin Hiley, Yousuf M AlSuleimani
Publikováno v:
European Journal of Pharmacology. 702:1-11
The actions of the anandamide-like mono-unsaturated fatty acid oleoylethanolamide (OEA) were first linked to satiety and control of food intake and recently reported to relax resistance vessels. This study characterizes its vasorelaxant mechanisms. V
Publikováno v:
British Journal of Pharmacology. 164:839-852
Our view of the endothelium was transformed around 30 years ago, from one of an inert barrier to that of a key endocrine organ central to cardiovascular function. This dramatic change followed the discoveries that endothelial cells (ECs) elaborate th
Autor:
Pui Man Hoi, C. Robin Hiley
Publikováno v:
Cardiovascular Drug Reviews. 25:46-60
Oleamide (cis-9,10-octadecenoamide), a fatty acid primary amide discovered in the cerebrospinal fluid of sleep-deprived cats, has a variety of actions that give it potential as a signaling molecule, although these actions have not been extensively in
Autor:
C. Robin Hiley, Pui Man Hoi
Publikováno v:
British Journal of Pharmacology. 147:560-568
Oleamide (cis-9-octadecenoamide) exhibits some cannabimimetic responses despite its low affinities at the currently known cannabinoid receptors. Here we have investigated whether or not it is a vasorelaxant in rat small mesenteric arteries. Oleamide
Publikováno v:
Trends in Pharmacological Sciences. 27:1-4
Increasing evidence suggests that some cannabinoids mediate their effects independently of the known cannabinoid CB(1) and CB(2) receptors. Two recently published patents indicate that several cannabinoid receptor ligands also bind to the orphan G-pr
Publikováno v:
British Journal of Pharmacology. 146:809-816
Although the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide share a similar pharmacology, 2-AG reportedly limits myocardial ischaemia–reperfusion injury whereas anandamide does not. We therefore investigated whether or not anandamide
Autor:
W-S Vanessa Ho, C. Robin Hiley
Publikováno v:
Journal of Pharmacy and Pharmacology. 56:869-875
Virodhamine is a recently identified novel endocannabinoid. Cannabinoids may evoke vasorelaxation through novel receptors in the vasculature and/or through release of vasodilator peptides from sensory nerve endings. Virodhamine induced endothelium-de
Autor:
C. Robin Hiley, W S Vanessa Ho
Publikováno v:
British Journal of Pharmacology. 139:585-597
Three cannabinoid receptor agonists, anandamide (CB1 receptor-selective) and the aminoalkyl-indoles, JWH 015(2-methyl-1-propyl-1H-indol-3-yl)-1-napthalenylmethanone; (CB2 receptor-selective), R-(+)-WIN 55,212-2 (R-(+)-[2,3-dihydro-5-methyl-3-(4-morph
Publikováno v:
British Journal of Pharmacology. 139:661-671
Vasorelaxation and hyperpolarization of endothelial cells by adenosine 5′-[β-thio]diphosphate (ADPβS) and adenosine 5′-[γ-thio]triphosphate (ATPγS) were studied in rat-isolated mesenteric artery. Effects from stimulation of P2X receptors were